Linzess (linaclotide)

Manufacturer:
AbbVie | Ironwood Pharmaceuticals
Route of Administration: 
Oral
Site of Care:
Outpatient
Website: 
    Enrollment Forms:
    Synergen Prescription Form

    Approved Indication:

    • treatment of irritable bowel syndrome with constipation in adults
    • treatment of chronic idiopathic constipation in adults
    • treatment of functional constipation in pediatric patients 6 to 17 years of age

    Conditions:

    • Irritable Bowel Syndrome with Constipation (IBS-C)
    • Chronic Idiopathic Constipation (CIC)
    • Functional Constipation

    Therapeutic Area:

    • Gastroenterology